search
HOME / NEWS / INCE INVESTMENTS / INCE Capital Leads Nearly ¥100m Pre-A Financing for Great Robotics
INCE Capital Leads Nearly ¥100m Pre-A Financing for Great Robotics
2022.06.30

Great Robotics announces it has raised nearly 100 million yuan in Pre-A funding led by INCE Capital. The company will use the money for the development of the core platform for surgical robots, testing and clinical trials of full-process surgical robots with master-slave control for minimally invasive orthopaedic surgery, as well as the development of a new generation of minimally invasive robots for composite guided vascular intervention and similar products.

                                 

Stella Zhou, Founding Partner of INCE Capital, noted, “Medical robots, especially minimally invasive ones, have bright prospects in orthopedics. The core team of Great Robotics have cooperated for over a decade and accumulated experience in building successful products, giving them a head start for further R&D. It is one of the promising startups we are looking for, driven by technology and growing with the application of technology. We hope they can branch out into more clinical fields and see the bigger picture.”

                                 

Great Robotics develops precise image-guided surgical robots based on a core technology platform. Its solution for healthcare professionals constitutes a “metaverse” of precise intraoperative imaging, smart software, multi-arm surgical robots with master-slave control, proprietary consumables, and remote surgery. 

                                 

The company is devoting itself to two major fields. One is the platform of full-process surgical robots with master-slave control for minimally invasive orthopaedic surgery, which is progressing well and will enter the clinical trial this year. It is mainly used for minimally invasive treatment of degenerative disc diseases, such as lumbar disc herniation, lumbar spinal stenosis, lumbar facet joint cyst, discogenic pain. The other is the minimally invasive robot for composite guided vascular intervention, which will be thrown into clinical trials in the first half of next year.

                                 

INCE Capital led this round of financing, which was the second fundraising Great Robotics has completed in one year. Oriental Jiafu participated and Insight & Reliability Capital served as the financial adviser.